The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective
Crossref DOI link: https://doi.org/10.1007/s40263-016-0310-2
Published Online: 2016-02-15
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brodtkorb, Thor-Henrik
Bell, Melissa
Irving, Adam H.
Laramée, Philippe
Text and Data Mining valid from 2016-02-01